Ruggaard & Associates’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $325K | Sell |
800
-115
| -13% | -$46.6K | 0.13% | 88 |
|
|
2025
Q1 | $455K | Sell |
915
-15
| -2% | -$7.47K | 0.2% | 66 |
|
|
2024
Q4 | $484K | Sell |
930
-157
| -14% | -$81.7K | 0.21% | 64 |
|
|
2024
Q3 | $673K | Sell |
1,087
-9
| -0.8% | -$5.57K | 0.29% | 44 |
|
|
2024
Q2 | $606K | Sell |
1,096
-15
| -1% | -$8.3K | 0.28% | 53 |
|
|
2024
Q1 | $646K | Sell |
1,111
-79
| -7% | -$45.9K | 0.31% | 46 |
|
|
2023
Q4 | $632K | Buy |
1,190
+43
| +4% | +$22.8K | 0.33% | 43 |
|
|
2023
Q3 | $581K | Buy |
1,147
+350
| +44% | +$177K | 0.35% | 43 |
|
|
2023
Q2 | $416K | Buy |
797
+91
| +13% | +$47.5K | 0.24% | 64 |
|
|
2023
Q1 | $407K | Buy |
+706
| New | +$407K | 0.25% | 62 |
|